What is the first step in managing a middle-aged lady with a large swelling on her back, anorexia, night sweats, and weight loss, suspected of having tuberculosis (TB) with a cold abscess?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025 • View editorial policy

From the Guidelines

The first next step in managing this middle-aged lady with a large back swelling and constitutional symptoms suggestive of tuberculosis (TB) would be option D: Aspiration only. This approach allows for obtaining a sample of the fluid from the suspected cold abscess for diagnostic confirmation before initiating definitive treatment. The aspirated material should be sent for acid-fast bacilli (AFB) staining, TB culture, GeneXpert MTB/RIF testing, and cytology to confirm the diagnosis of tuberculous abscess. This is crucial because the clinical presentation of night sweats, weight loss, anorexia, and a large swelling is highly suggestive of TB but requires microbiological confirmation, as emphasized by the guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities 1. Premature drainage or incision without diagnosis could lead to chronic sinus formation and delayed healing. Similarly, starting anti-TB medication (option E) without confirming the diagnosis would be inappropriate as it commits the patient to 6-9 months of potentially unnecessary treatment with significant side effects. Once TB is confirmed through aspiration and testing, a complete anti-TB regimen can be initiated, typically consisting of isoniazid, rifampin, ethambutol, and pyrazinamide for the initial phase, followed by isoniazid and rifampin for the continuation phase, as recommended by the executive summary of the official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines for the treatment of drug-susceptible tuberculosis 2. Key considerations in the management of TB include the importance of early diagnosis and treatment to prevent morbidity and mortality, as well as the need for careful evaluation and monitoring to ensure effective treatment and prevent the development of drug-resistant TB, as highlighted in the American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America guidelines for controlling tuberculosis in the United States 3. The use of case management interventions, including patient education and counseling, field and home visits, and integration and coordination of care with specialists and medical home, can also improve outcomes for patients with TB, as suggested by the clinical practice guidelines for the treatment of drug-susceptible tuberculosis 2. Overall, a comprehensive approach to the diagnosis and treatment of TB is essential to ensure optimal outcomes for patients and to prevent the transmission of this serious infectious disease.

From the FDA Drug Label

In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to Rifampin for Injection, USP and they should be repeated throughout therapy to monitor the response to treatment. The first next step is to obtain bacteriologic cultures to confirm the susceptibility of the organism to rifampicin before starting therapy, as the patient is suspected to have TB with a cold abscess 4.

  • The patient's symptoms, such as swelling, anorexia, night sweating, and loss of weight, suggest a possible infection that needs to be diagnosed and treated accordingly.
  • Aspiration or other diagnostic procedures may be necessary to collect samples for culture and susceptibility testing.
  • However, the provided drug label does not explicitly address the next step in the management of a patient with a suspected cold abscess, so a conservative approach would be to prioritize diagnostic testing to guide further treatment.

From the Research

Diagnosis and Treatment of Tuberculosis

  • The patient presents with symptoms of tuberculosis (TB), including a large swelling on her back, anorexia, night sweating, and weight loss 5, 6.
  • The first step in managing a patient with suspected TB is to confirm the diagnosis through laboratory tests, such as sputum culture or biopsy 7, 8.
  • However, in this case, the patient has a large swelling (cold abscess) that needs to be addressed promptly.

Management of Cold Abscess

  • The management of a cold abscess in TB involves drainage of the abscess, either through incision and drainage or aspiration 9.
  • Aspiration only (option D) may not be sufficient to drain the large abscess, and incision and drainage (option A) may be necessary to ensure complete drainage.
  • US-guided pigtail drain (option C) is another option for draining the abscess, especially if it is located in a difficult-to-reach area.

Next Step

  • Based on the symptoms and presentation, the first next step would be to drain the cold abscess, either through incision and drainage or US-guided pigtail drain, to relieve the patient's symptoms and prevent further complications 5, 9.
  • Anti-TB treatment (option E) should be started concurrently, but the drainage of the abscess takes priority to prevent further complications.

References

Research

Updates in the Treatment of Active and Latent Tuberculosis.

Seminars in respiratory and critical care medicine, 2018

Research

Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002

Research

Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.